Aspirin and prevention of cardiovascular risk;Aspirine et prévention du risque cardiovasculaire

Revue de Medecine Interne

Volumn 21, Issue SUPPL. 1, 2000, Pages 35-40

  Karila Cohen, D ^a   Gabriel Steg, P ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Angina; Aspirin; Myocardial infarction; Primary prevention; Secondary prevention; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANGINA PECTORIS; ARTERITIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; HEART ARRHYTHMIA; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; LEG; PRIMARY PREVENTION; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; VASCULARIZATION;

ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARRHYTHMIA; ARTERITIS; ASPIRIN; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; CORONARY ARTERY BYPASS; CYCLOOXYGENASE INHIBITORS; FIBRINOLYTIC AGENTS; HEART VALVE PROSTHESIS; HUMANS; LEG; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; RISK FACTORS;

EID: 0001837715     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DeWood MA, Spores J, Notske R, Mouser, LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural infarction. N Engl J Med 1980 ; 303 : 897-902.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS. Lancet 1988 ; ii : 349-60.
3. Stein B, Fuster V, Israel D, Cohen M, Badimon L, Badimon JJ, et al. Platelet inhibitor agents in cardiovascular disease: an update. J Am Coll Cardiol 1989 ; 14 : 813-36.
4. Antiplatelet Trialists'Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various category of patients. Br Med J 1994 ; 308 : 81-106.
5. Hamm C, Lorenz R, Bleifeld W, Kupper W, Wober W, Weber P. Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 1987 ; 10 : 998-1006.
6. Lewis Jr H. Unstable angina: status of aspirin and other forms of therapy. Circulation 1985 ; 72 : V155-V160.
7. Cairns J, Gent M, Singer J, Finnie KJ, Frogatt GM, Holder DA, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985 ; 313 : 1369-75.
8. Theroux P, Ouimet H, McCans J. Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988 ; 319 : 1105-11.
9. Wallentin L. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for rebascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. J Am Coll Cardiol 1991 ; 18 : 1587-93.
10. Nyman I, Larsson H, Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Lancet 1992 ; 340 : 497-501.
11. The Steering Commitee of the Physicians'Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989 ; 321 : 129-35.
12. Ridker P, Manson J, Gaziano J, Buring J, Hennekens C. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med 1991 ; 114 : 835-9.
13. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992 ; 340 : 1421-5.
14. Borzak S, Cannon C, Kraft P, Douthat L, Becker RC, Palmeri ST, et al. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol 1998 ; 81 : 678-81.
15. Barnathan E, Schwartz J, Taylor L, Laskey WK, Kleaveland JP, Kussmaul WG, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987 ; 76 : 125-34.
16. Schömig A, Neumann F, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996 ; 334 : 1084-9.
17. Lorenz R, Schacky C, Weber M, Meister W, Kotzur J, Reichardt B, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1984 : 1 : 1261-4.
18. Sanz G, Pajaron A. Alegria E, Coello I, Cardona M, Fournier JA, et al. Prevention of early a tocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario. Circulation 1990 ; 82 : 765-73.
19. Brown B, Cukingnan R, DeRouen T, Goede JN, Wong M, Fee HJ, et al. Improved graft patency in patients platelet-inhibiting therapy after coronary bypass surgery. Circulation 1985 ; 72 : 138-46.
20. Stein P. Dalen J, Goldman S, Schwartz L, Théroux P, Turpie A. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1995 ; 108 Suppl : S424-S430.
21. Hess H, Mietaschk A, Deichsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: a prospective double-blind angiographically controlled trial. Lancet 1985 ; 1 (415-9).
22. Peto R, Gray R, Collins R, Wheatley K. Hennekens C, Jamrozik, K. et al. A randomized trial of the effects of prophylactic daily aspirin among male British doctors. P Med J 1988 ; 296 : 320-31.
23. Hansson L, Zanchetti A, Carruthers S, Dahlöf B, Elmfeldt D, Julius S, et al. Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998 ; 351 : 1755-62.
24. Turpie A, Gent M. Laupacis A, Latour Y, Gunstensen J. Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993 ; 329 : 524-9.
25. Prystowsky E, Benson Jr D, Fuster V, Hart RG, Kay GN, Myerburg RJ, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on electrocardiography and electrocardiography, American Heart Association. Circulation 1996 ; 93 : 1262-77.
26. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991 ; 84 : 527-39.
27. Adgey A. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Eur Heart J 1998 ; 19 : D10-D21.
28. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996 ; 348 : 1329-39.